Otto Soepenberg
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
- Oncology 11
- Lung Cancer Research Studies 7
- Neutropenia and Cancer Infections 4
- Cancer Treatment and Pharmacology 2
- Drug Transport and Resistance Mechanisms 2
- Colorectal Cancer Treatments and Studies 1
-
- Cancer therapeutics and mechanisms 10
- Co-authors
- Jaap Verweij (11 shared papers)Alex Sparreboom (10 shared papers)Walter J. Loos (3 shared papers)Diederik F.S. Kehrer (1 shared paper)Maja J.A. de Jonge (5 shared papers)Ferry A.L.M. Eskens (3 shared papers)Sylvie Assadourian (2 shared papers)Herlinde Dumez (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (2 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)Journal of Chromatography B (1 paper)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Otto Soepenberg
14 papers receiving 323 citations
Peers
Comparison fields: 5 of 54
- Biomaterials 109
- Toxicology 25
- Oncology 160
- Pharmaceutical Science 24
- Molecular Medicine 17
Countries citing papers authored by Otto Soepenberg
This map shows the geographic impact of Otto Soepenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Soepenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Soepenberg more than expected).
Fields of papers citing papers by Otto Soepenberg
This network shows the impact of papers produced by Otto Soepenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Soepenberg. The network helps show where Otto Soepenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Otto Soepenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 94 | |
| 2 | 2005 | 70 | |
| 3 | 2005 | 56 | |
| 4 | 2004 | 29 | |
| 5 | 2005 | 25 | |
| 6 | 2007 | 17 | |
| 7 | 2003 | 12 | |
| 8 | 1994 | 9 | |
| 9 | 2004 | 9 | |
| 10 | 2003 | 7 | |
| 11 | 2017 | 7 | |
| 12 | 2011 | 2 | |
| 13 | 2003 | 1 | |
| 14 | 2004 | 1 |
About Otto Soepenberg
Otto Soepenberg is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hematology and Cancer Research, having authored 14 papers that have together received 339 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Lung Cancer Research Studies (7 papers), Neutropenia and Cancer Infections (4 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Treatments and Mutations (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Biomaterials (109 citations), Toxicology (25 citations), Oncology (160 citations), Pharmaceutical Science (24 citations) and Molecular Medicine (17 citations). Otto Soepenberg has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Jaap Verweij, Alex Sparreboom, Walter J. Loos, Diederik F.S. Kehrer, Maja J.A. de Jonge, Ferry A.L.M. Eskens, Sylvie Assadourian, Herlinde Dumez, Ger‐Jan Sanderink and J. Wanders. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, European Journal of Cancer, Annals of Oncology and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.